There were only nine total primary endpoint events — defined as death within 45 days of ischemic stroke in the device group, and 16 in the medical therapy group, for a risk reduction of 46.6%. The relative risk was 0.534 (95% CI 0.234-1.220; P=.157). In an intention-to-treat ...